
1. malar j. 2020 aug 27;19(1):306. doi: 10.1186/s12936-020-03379-2.

comparative evaluation two commercial real-time pcr kits (quantifast™ and
abtes™) detection plasmodium knowlesi plasmodium species 
sabah, malaysia.

nuin na(1), tan af(2)(3), lew yl(4), piera ka(4)(5), william t(4)(6)(7), rajahram
gs(4)(7), jelip j(8), dony jf(9), mohammad r(9), cooper dj(4)(5), barber
be(4)(5)(10), anstey nm(4)(5), chua th(1), grigg mj(11)(12).

author information: 
(1)faculty medicine health sciences, universiti malaysia sabah, kota
kinabalu, sabah, malaysia.
(2)infectious diseases society kota kinabalu - menzies school health research 
clinical research unit, kota kinabalu, sabah, malaysia.
angelicafiona.tan@menzies.edu.au.
(3)global tropical health division, menzies school health research,
charles darwin university, darwin, po box 41096, casuarina, nt, 0810, australia. 
angelicafiona.tan@menzies.edu.au.
(4)infectious diseases society kota kinabalu - menzies school health research 
clinical research unit, kota kinabalu, sabah, malaysia.
(5)global tropical health division, menzies school health research,
charles darwin university, darwin, po box 41096, casuarina, nt, 0810, australia.
(6)gleneagles hospital, kota kinabalu, sabah, malaysia.
(7)clinical research centre, queen elizabeth hospital, ministry health, kota
kinabalu, sabah, malaysia.
(8)ministry health, kuala lumpur, malaysia.
(9)state public health laboratory, sabah department health, kota kinabalu,
malaysia.
(10)qimr berghofer medical research institute, brisbane, qld, australia.
(11)infectious diseases society kota kinabalu - menzies school health research
clinical research unit, kota kinabalu, sabah, malaysia.
matthew.grigg@menzies.edu.
(12)global tropical health division, menzies school health research,
charles darwin university, darwin, po box 41096, casuarina, nt, 0810, australia. 
matthew.grigg@menzies.edu.

background: monkey parasite plasmodium knowlesi emerging public health 
issue southeast asia. sabah, malaysia, p. knowlesi dominant
cause human malaria. molecular detection methods p. knowlesi essential
for accurate diagnosis monitoring progress towards malaria elimination 
other plasmodium species. however, recent commercially available pcr malaria kits
have unpublished p. knowlesi gene targets evaluated against
clinical samples.
methods: two real-time pcr methods currently used sabah confirmatory
malaria diagnosis surveillance reporting evaluated: quantifast™
multiplex pcr kit (qiagen, germany) targeting p. knowlesi 18s ssu rrna; and
the abtes™ malaria 5 qpcr ii kit (aitbiotech, singapore), undisclosed p. 
knowlesi gene target. diagnostic accuracy evaluated using 52 p. knowlesi, 25 
plasmodium vivax, 21 plasmodium falciparum, 10 plasmodium malariae clinical
isolates, 26 malaria negative controls, compared validated
reference nested pcr assay. limit detection (lod) pcr method 
plasmodium species also evaluated.
results: sensitivity quantifast™ abtes™ assays detecting p.
knowlesi comparable 98.1% (95% ci 89.7-100) 100% (95% ci 93.2-100),
respectively. specificity quantifast™ abtes™ p. knowlesi high 
at 98.8% (95% ci 93.4-100) assays. quantifast™ assay demonstrated
falsely-positive mixed plasmodium species low parasitaemias the
primary lod analysis. diagnostic accuracy pcr kits detecting p.
vivax, p. falciparum, p. malariae comparable p. knowlesi. abtes™
assay demonstrated lower lod p. knowlesi of ≤ 0.125 parasites/µl compared
to quantifast™ lod 20 parasites/µl. hospital microscopy demonstrated 
sensitivity 78.8% (95% ci 65.3-88.9) specificity 80.4% (95% ci
67.6-89.8) compared reference pcr detecting p. knowlesi.
conclusion: quantifast™ abtes™ commercial pcr kits performed well the
accurate detection p. knowlesi infections. although quantifast™ kit is
cheaper, abtes™ kit demonstrated lower lod, supporting use a
second-line referral-laboratory diagnostic tool sabah, malaysia.

doi: 10.1186/s12936-020-03379-2 
pmcid: pmc7457277
pmid: 32854695 

